Literature DB >> 3989909

Immortalization of rat embryo fibroblasts by an adenovirus 2 mutant expressing a single functional E1a protein.

D R Hurwitz, G Chinnadurai.   

Abstract

Expression of the adenovirus E1a and E1b genes is required for transformation of nonpermissive rodent cells. Differential splicing of the E1a precursor RNA molecules results in the production of two early mRNAs, 13S and 12S, which encode a 289-amino-acid-residue (289R) and 243R protein, respectively. Previously we constructed a mutant virus, dl231, which can only produce normal 289R protein from the E1a gene. In this report we demonstrate that dl231 induced focal transformation of primary rat embryo fibroblasts at 20% of the level of wild-type virus. dl231 transformants were immortalized and produced normal levels of E1a 13S and E1b mRNAs but only minute levels of defective E1a 12S mRNA. These transformants only minimally expressed the transformation phenotype and were similar to untransformed cells. Unlike wild-type transformants, they had a more fibroblastic morphology, were contact inhibited, grew to only low saturation density, and were limited in their ability to grow in an anchorage-independent manner in soft agar. We conclude that the 289R E1a protein can mediate immortalization of primary cells and that the 243R E1a protein is required to elicit the full transformation phenotype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989909      PMCID: PMC254805     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells.

Authors:  G Chinnadurai; H M Rho; R B Horton; M Green
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

3.  Viral nucleic acid sequences in transformed cells. IV. A study of the sequences of adenovirus 5 DNA and RNA in four lines of adenovirus 5-transformed rodent cells using specific fragments of the viral genome.

Authors:  S J Flint; J Sambrook; J F Williams; P A Sharp
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

4.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

5.  Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;.

Authors:  P H Gallimore
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

6.  Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome.

Authors:  D J Spector; M McGrogan; H J Raskas
Journal:  J Mol Biol       Date:  1978-12-15       Impact factor: 5.469

7.  Defective transforming capacity of adenovirus type 5 host-range mutants.

Authors:  F L Graham; T Harrison; J Williams
Journal:  Virology       Date:  1978-05-01       Impact factor: 3.616

8.  Adenovirus type 2 mRNA in transformed cells: map positions and difference in transport time.

Authors:  M C Wilson; S G Sawicki; M Salditt-Georgieff; J E Darnell
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

9.  Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA.

Authors:  A J Van der Eb; C Mulder; F L Graham; A Houweling
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

View more
  8 in total

1.  Establishment, characterization and immortalization of a fibroblast cell line from the Chinese red belly toad Bombina maxima skin.

Authors:  Yang Xiang; Qian Gao; Weiting Su; Lin Zeng; Jinhuan Wang; Yi Hu; Wenhui Nie; Xutong Ma; Yong Zhang; Wenhui Lee; Yun Zhang
Journal:  Cytotechnology       Date:  2011-09-27       Impact factor: 2.058

2.  Differential nuclear localization of the major adenovirus type 2 E1a proteins.

Authors:  R C Schmitt; M L Fahnestock; J B Lewis
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Effect of E1A and E1B viral proteins on the expression of a calcium ionophore-inducible gene and its promoter.

Authors:  A Y Lin; A S Lee
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

4.  In vitro splicing of adenovirus E1A transcripts: characterization of novel reactions and of multiple branch points abnormally far from the 3' splice site.

Authors:  R Gattoni; P Schmitt; J Stevenin
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

5.  Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A.

Authors:  T Jelinek; D S Pereira; F L Graham
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

6.  Recognition of adenovirus E1A gene products on immortalized cell surfaces by cytotoxic T lymphocytes.

Authors:  D Bellgrau; T A Walker; J L Cook
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA.

Authors:  B Ferguson; B Krippl; O Andrisani; N Jones; H Westphal; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

8.  Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells.

Authors:  J L Cook; T A Walker; A M Lewis; H E Ruley; F L Graham; S H Pilder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.